Researchers have discovered that immune cells packed with lipid droplets accumulate in the brains of patients with severe multiple sclerosis and appear to drive ongoing inflammation and tissue damage. The findings suggest that targeting immune cell lipid metabolism could represent a new therapeutic avenue for slowing MS progression. — Photo by National Institute of Allergy and Infectious Diseases on Unsplash (Unsplash License)
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
